2026 marks BIO-Europe’s evolution from partnering-led conference into the continent’s largest biopharma strategy forum Expands its program to convene the full C-suite of strategy leaders, building on its commitment to open dialogue and constructive partnerships Seven integrated tracks and high-impact plenary sessions to address the forces reshaping the global biopharma industry London, UK – 18 […]
Barcelona, Spain – 9 April 2025: Oxolife, the female fertility biotech focused on increasing live birth rates by enhancing embryo implantation in women undergoing assisted reproductive technology (ART) fertility treatment, today announces that Agnès Arbat, its Chief Executive Officer, has been awarded the prestigious EU Women Innovators Prize at the European Innovation Council (EIC) Summit […]
Xeltis is one of only seven companies to successfully pass evaluation phase of EIC Strategic Technologies for Europe Platform (STEP) Scale Up call Funding to support commercialization of its groundbreaking bioresorbable vascular conduits EINDHOVEN, The Netherlands, 8 April 2025 – Xeltis, a leading developer of transformative implants that enable the natural creation of living and […]
CNS specialist continues growth strategy across Europe and beyond, optimizing commercial efficiency and maintaining strong focus on innovation Barcelona, Spain and Düsseldorf, Germany – 14 November 2024 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its rebranding as Neuraxpharm […]
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza’s commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for differentiated ADCs BigHat’s artificial intelligence (AI)/machine learning (ML)-powered antibody design platform, Milliner™ was used to design a highly differentiated […]
